These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 30507073

  • 21. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB, Barazangi N, Chen C, Wong C, Grosvenor D, Rose J, Bedenk A, Morrow M, McDermott D, Hove JD, Tong DC.
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [Abstract] [Full Text] [Related]

  • 22. Validation of TURN, a simple predictor of symptomatic intracerebral hemorrhage after IV thrombolysis.
    Asuzu D, Nystrӧm K, Amin H, Schindler J, Wira C, Greer D, Chi NF, Halliday J, Sheth KN.
    Clin Neurol Neurosurg; 2016 Jul; 146():71-5. PubMed ID: 27152469
    [Abstract] [Full Text] [Related]

  • 23. Fibrinogen Depletion Coagulopathy Predicts Major Bleeding After Thrombolysis for Ischemic Stroke: A Multicenter Study.
    Romoli M, Vandelli L, Bigliardi G, Naccarato M, Moller J, Balestrino M, Giammello F, Gentile M, Dell'Acqua ML, Manganotti P, Forlivesi S, Melis M, Picchetto L, Rosafio F, Furlanis G, Testoni S, Piras V, Malfatto L, Musolino RF, Scali I, Maffei S, Migliaccio L, Trenti T, Mancini R, Marietta M, Randi V, Meletti S, Zini A.
    Stroke; 2022 Dec; 53(12):3671-3678. PubMed ID: 36039754
    [Abstract] [Full Text] [Related]

  • 24. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C, Bai Q, Zhao Z, Zhang J.
    Cerebrovasc Dis; 2019 Dec; 48(1-2):85-90. PubMed ID: 31587000
    [Abstract] [Full Text] [Related]

  • 25. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
    Majidi S, Leon Guerrero CR, Burger KM, Sigounas D, Olan WJ, Qureshi AI.
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
    [Abstract] [Full Text] [Related]

  • 26. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S.
    JAMA; 1999 Dec 01; 282(21):2019-26. PubMed ID: 10591384
    [Abstract] [Full Text] [Related]

  • 27. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
    Šaňák D, Jakubíček S, Černík D, Herzig R, Kunáš Z, Mikulík R, Ostrý S, Reif M, Rohan V, Tomek A, Veverka T.
    J Stroke Cerebrovasc Dis; 2018 Sep 01; 27(9):2479-2483. PubMed ID: 29807757
    [Abstract] [Full Text] [Related]

  • 28. Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score.
    Skagen K, Skjelland M, Russell D, Jacobsen EA.
    J Stroke Cerebrovasc Dis; 2015 Jul 01; 24(7):1532-9. PubMed ID: 25922156
    [Abstract] [Full Text] [Related]

  • 29. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
    Tong X, George MG, Yang Q, Gillespie C.
    Int J Stroke; 2014 Aug 01; 9(6):728-34. PubMed ID: 24024962
    [Abstract] [Full Text] [Related]

  • 30. Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis.
    Matosevic B, Knoflach M, Werner P, Pechlaner R, Zangerle A, Ruecker M, Kirchmayr M, Willeit J, Kiechl S.
    Neurology; 2013 Mar 26; 80(13):1216-24. PubMed ID: 23486872
    [Abstract] [Full Text] [Related]

  • 31. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG, Chaudhry SA, Hassan AE, Peacock JM, Lakshminarayan K, Tsai A, Luepker R, Anderson DC, Qureshi AI.
    Cerebrovasc Dis; 2012 Mar 26; 34(5-6):400-5. PubMed ID: 23221276
    [Abstract] [Full Text] [Related]

  • 32. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M, Tütüncü S, Fiebach JB, Scheitz JF, Audebert HJ, Nolte CH.
    J Stroke Cerebrovasc Dis; 2013 May 26; 22(4):550-3. PubMed ID: 23433783
    [Abstract] [Full Text] [Related]

  • 33. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
    Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, Castaldo J, Frey J, Gebel J, Kasner S, Kidwell C, Kwiatkowski T, Libman R, Mackenzie R, Scott P, Starkman S, Thurman RJ, CLEAR Trial Investigators.
    Stroke; 2008 Dec 26; 39(12):3268-76. PubMed ID: 18772447
    [Abstract] [Full Text] [Related]

  • 34. Interaction of Recanalization, Intracerebral Hemorrhage, and Cerebral Edema After Intravenous Thrombolysis.
    Cheripelli BK, Huang X, MacIsaac R, Muir KW.
    Stroke; 2016 Jul 26; 47(7):1761-7. PubMed ID: 27301943
    [Abstract] [Full Text] [Related]

  • 35. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M, Matthis C, Eggers J.
    J Stroke Cerebrovasc Dis; 2014 Jan 26; 23(1):7-11. PubMed ID: 22578915
    [Abstract] [Full Text] [Related]

  • 36. Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register.
    Keselman B, Cooray C, Vanhooren G, Bassi P, Consoli D, Nichelli P, Peeters A, Sanak D, Zini A, Wahlgren N, Ahmed N, Mazya MV.
    Eur J Neurol; 2019 Aug 26; 26(8):1091-1097. PubMed ID: 30793434
    [Abstract] [Full Text] [Related]

  • 37. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
    Shahjouei S, Tsivgoulis G, Bavarsad Shahripour R, Jones GM, Alexandrov AV, Zand R.
    J Stroke Cerebrovasc Dis; 2015 Dec 26; 24(12):2685-93. PubMed ID: 26542821
    [Abstract] [Full Text] [Related]

  • 38. Fibrinogen depletion and intracerebral hemorrhage after thrombolysis for ischemic stroke: a meta-analysis.
    Romoli M, Giannandrea D, Zini A.
    Neurol Sci; 2022 Feb 26; 43(2):1127-1134. PubMed ID: 34212264
    [Abstract] [Full Text] [Related]

  • 39. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA, SITS International and VISTA-plus investigators.
    Int J Stroke; 2014 Aug 26; 9(6):705-10. PubMed ID: 25042855
    [Abstract] [Full Text] [Related]

  • 40. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S, McWilliams-Dunnigan L, Blackham KL, Kirchner HL, Sundararajan S, Sunshine JL, Tarr RW, Selman WR, Landis DM, Suarez JI.
    J Stroke Cerebrovasc Dis; 2008 Sep 26; 17(5):266-72. PubMed ID: 18755405
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.